Atossa Therapeutics, Inc. has announced plans for a new Phase 3 clinical trial, SMART 2.0, which will explore the effectiveness of oral (Z)-endoxifen in reducing interval breast cancer among high-risk ...
Hosted on MSN
First shots of the 2026 Smart #2 revealed
Spiritual successor to the Smart ForTwo All-electric city car Now in final stages of development Expected end of 2026 This is our first look at the spiritual successor to the, dare we say it, iconic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback